Evidence map›Paper›PMID 40298471›Full record

ArticleAntibiotics (Basel, Switzerland)2025

In Vitro and In Vivo Investigations into the Potential of Quinazoline and Quinoline Derivatives as NorA Efflux Pump Inhibitors Against Resistant

Nishtha Chandal, Nidhi Sharma, Giada Cernicchi, Tommaso Felicetti, Tommaso Rondini, Mattia Acito, Hemraj Nandanwar, Stefano Sabatini

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Polyphenolic compounds inFrontiers in pharmacology · 2026
    Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nishtha ChandalClinical Microbiology & Antimicrobial Research Laboratory, CSIR-Institute of Microbial Technology, Sector 39-A, Chandigarh 60036, Punjab and Haryana, India.ORCID 0009-0006-5625-6023
Nidhi SharmaClinical Microbiology & Antimicrobial Research Laboratory, CSIR-Institute of Microbial Technology, Sector 39-A, Chandigarh 60036, Punjab and Haryana, India.
Giada CernicchiDepartment of Pharmaceutical Sciences, Section of Chemistry and Drug Technology, University of Perugia, 06123 Perugia, Italy.ORCID 0000-0002-3591-0210
Tommaso FelicettiDepartment of Pharmaceutical Sciences, Section of Chemistry and Drug Technology, University of Perugia, 06123 Perugia, Italy.ORCID 0000-0001-9369-8564
Tommaso RondiniDepartment of Pharmaceutical Sciences, Section of Biochemical and Health Sciences, University of Perugia, 06123 Perugia, Italy.
Mattia AcitoDepartment of Pharmaceutical Sciences, Section of Biochemical and Health Sciences, University of Perugia, 06123 Perugia, Italy.ORCID 0000-0003-1808-1999
Hemraj NandanwarClinical Microbiology & Antimicrobial Research Laboratory, CSIR-Institute of Microbial Technology, Sector 39-A, Chandigarh 60036, Punjab and Haryana, India.ORCID 0000-0003-4301-6355
Stefano SabatiniDepartment of Pharmaceutical Sciences, Section of Chemistry and Drug Technology, University of Perugia, 06123 Perugia, Italy.ORCID 0000-0003-0971-3536

Funding

European Union - NextGenerationEU under the Italian Ministry of University and Research (MUR) National Innovation Ecosystem grant ECS00000041 - VITALITY - CUP J97G22000170005
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimicrobial resistance (AMR)antimicrobial resistance breakers (ARBs)ciprofloxacinefflux pump inhibitors (EPIs)Staphylococcus aureus

Identifiers

PMID40298471
PMCPMC12024145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.